Galderma Group AG
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GALDY | TEVA | TAK | ALKS | PBH | ELAN | |
|---|---|---|---|---|---|---|
| Market cap | 52.88B | 46.75B | 64.99B | 7.45B | 2.33B | 11.36B |
| P/E (TTM) | 62.1 | 66.8 | — | 116.9 | 13.8 | — |
| Forward P/E | 7.2 | 13.0 | 38.4 | 24.6 | 9.7 | 17.7 |
| Price/book | 6.4 | 6.0 | 1.3 | 4.1 | 1.2 | 1.7 |
| Dividend yield | 0.21% | — | 3.09% | — | — | — |
| 1-year change | +19.91% | +113.56% | +41.75% | +44.74% | −23.44% | +3.58% |
| Today | +6.83% | −1.33% | +2.08% | +2.15% | +2.79% | +0.91% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All GALDY news ›Ozempic, Botox and the anti-aging boom: Galderma CEO on what's driving beauty spending
CNBC Ozempic, Botox and the anti-aging boom: Galderma CEO on what's driving beauty spending
Galderma lifts outlook for second quarter in a row after sales jump
ZURICH, Oct 22 (Reuters) – Swiss skincare company Galderma on Thursday nudged up its full-year sales guidance for the second time in two quarters after robust sales growth during the first nine months, driven particularly by its…
Galderma delivers net sales of 4.765 B USD in the first nine months, up 25.1% at constant currency year-on-year, and rai
Galderma recorded net sales of USD 4.765 billion in the first nine months of 2026, representing year-on-year growth of 25.1% at constant currency. Growth was predominantly driven by volume and complemented by a favorable product mix.…
A Galderma handout image shows a patient receiving a Sculptra injectable in Miami
The Daily News | Texas' Oldest Newspaper Sorry, an error occurred. Account processing issue - the email address may already exist Must be at least 8 characters, not contain repeating characters (e.g., 111), and not contain sequential…
Galderma Receives FDA Approval for Restylane® Defyne for Chin Augmentation
Feb 01, 2021, 08:00 ET For more information about Restylane Defyne for chin, visit RestylaneUSA.com. To earn exclusive rewards, bonuses and discounts on Galderma's aesthetic treatments, join the ASPIRE Rewards program. To learn more about…
Cetaphil Maker Galderma to Buy ZO Skin Health for $1.5 Billion in Medical Skincare Push
National Legal News, Information & Blogs Galderma, the Swiss dermatology company behind Cetaphil and Alastin, has agreed to buy ZO Skin Health for $1.5 billion in cash, giving the company a much larger position in physician-dispensed…
Galderma to snap up California-based ZO Skin Health for USD 1.5 billion
Swiss skincare group Galderma announced on Wednesday, October 14, that it has agreed to acquire California-based ZO Skin Health for an enterprise value of USD 1.5 billion (EUR 1.3 billion), strengthening its position in medical skincare.…
Switzerland: Galderma agrees to acquire ZO Skin Health from Blackstone for US$1.5bn
Galderma, a Swiss-based listed pure-play dermatology company, has agreed to acquire ZO Skin Health, a US-based physician-dispensed skincare brand, from its shareholders, including funds managed by Blackstone Tactical Opportunities, a…
Galderma to Acquire ZO Skin Health in US$1.5 Billion Deal
Galderma has agreed to acquire ZO Skin Health for US$1.5 billion, expanding its physician-dispensed skincare portfolio and strengthening its position in dermatology and medical aesthetics. Galderma to Acquire ZO Skin Health in US$1.5…
Swiss Stocks Extend Gains; Galderma Agrees $1.5 Billion Purchase of US Skincare Brand
The Swiss Market Index rose for a fourth consecutive session, ending 1.45% higher on Wednesday, as investors gauged the latest third-quarter updates and a major deal in the skincare industry amid a... Swiss Stocks Extend Gains; Galderma…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com14
-
tradingview.com3
-
biospace.com2
-
centraloregondaily.com2
-
dermatologytimes.com2
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 57 articles, not a forecast.